Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon Robertson

Showing results (71-80 of 116) with videos related to

Pageof 12
Sort By:
Nature Methods|September 14, 2010
Alternative expression analysis by RNA sequencingMalachi Griffith, Obi L Griffith, Jill Mwenifumbo, et al.
BMC Genomics|August 15, 2013
Barnacle: detecting and characterizing tandem duplications and fusions in transcriptome assembliesLucas Swanson, Gordon Robertson, Karen L Mungall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2019
Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck CancerAnthony D Saleh, Hui Cheng, Scott E Martin, et al.
Oncotarget|April 2, 2016
miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancerYinghong Pan, Gordon Robertson, Lykke Pedersen, et al.
Nature Methods|October 12, 2010
De novo assembly and analysis of RNA-seq dataGordon Robertson, Jacqueline Schein, Readman Chiu, et al.
Oncogene|April 24, 2023
The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responsesZhiping Li, Xuanmao Jiao, A Gordon Robertson, et al.
Research Square|January 30, 2023
The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responsesZhiping Li, Xuanmao Jiao, A Gordon Robertson, et al.
Oncotarget|April 14, 2017
Correction: miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancerYinghong Pan, Gordon Robertson, Lykke Pedersen, et al.
Nucleic Acids Research|November 17, 2007
ORegAnno: an open-access community-driven resource for regulatory annotationObi L Griffith, Stephen B Montgomery, Bridget Bernier, et al.
Science (New York, N.Y.)|October 27, 2018
The chromatin accessibility landscape of primary human cancersM Ryan Corces, Jeffrey M Granja, Shadi Shams, et al.
Pageof 12

Showing results (71-80 of 116) with videos related to

Sort By:
Pageof 12
Nature Methods|September 14, 2010
Alternative expression analysis by RNA sequencingMalachi Griffith, Obi L Griffith, Jill Mwenifumbo, et al.
BMC Genomics|August 15, 2013
Barnacle: detecting and characterizing tandem duplications and fusions in transcriptome assembliesLucas Swanson, Gordon Robertson, Karen L Mungall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2019
Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck CancerAnthony D Saleh, Hui Cheng, Scott E Martin, et al.
Oncotarget|April 2, 2016
miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancerYinghong Pan, Gordon Robertson, Lykke Pedersen, et al.
Nature Methods|October 12, 2010
De novo assembly and analysis of RNA-seq dataGordon Robertson, Jacqueline Schein, Readman Chiu, et al.
Oncogene|April 24, 2023
The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responsesZhiping Li, Xuanmao Jiao, A Gordon Robertson, et al.
Research Square|January 30, 2023
The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responsesZhiping Li, Xuanmao Jiao, A Gordon Robertson, et al.
Oncotarget|April 14, 2017
Correction: miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancerYinghong Pan, Gordon Robertson, Lykke Pedersen, et al.
Nucleic Acids Research|November 17, 2007
ORegAnno: an open-access community-driven resource for regulatory annotationObi L Griffith, Stephen B Montgomery, Bridget Bernier, et al.
Science (New York, N.Y.)|October 27, 2018
The chromatin accessibility landscape of primary human cancersM Ryan Corces, Jeffrey M Granja, Shadi Shams, et al.
Pageof 12